Shayan Mohammadmoradi: Excited to Co-Chair the 2028 Hemostasis Gordon Research Seminar
Shayan Mohammadmoradi, Vascular Biology and Platelet Function Scientist at University of Kentucky, CEO at Moradi Enterprise, shared a post on LinkedIn:
”What a fantastic week at the 2026 Hemostasis GRS/C! The science, discussions, collaborations, and friendships made this an unforgettable experience.
I am especially excited to share that my good friend and colleague Ana Sachetto and I have been selected as the incoming Co-Chairs of the 2028 Hemostasis Gordon Research Seminar!
We are honored by the opportunity and already looking forward to creating an engaging, inclusive, and memorable program for the next generation of our field.
A huge thank you to the Chairs and Vice Chairs of the 2026 GRC for creating such a phenomenal program.
See you in 2028 and stay tuned!”
Stay updated with Hemostasis Today.
-
Sep 1, 2026, 04:27Ruth Fein: The Patient Impact of Transfusion Dependence in Myelofibrosis
-
Sep 1, 2026, 02:41Richard Buka: Win a Trip to ASH or ISTH 2027
-
Sep 1, 2026, 02:38Christian’s Journey to Stability on Avatrombopag – ITP Support Association
-
Sep 1, 2026, 02:35Alexis Guédon: Is IL-6 Pathway Inhibition Reduce Cardiovascular Risk in Giant Cell Arteritis?
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
-
Aug 31, 2026, 16:47Improving Outcomes in AF-Related Stroke Beyond Anticoagulation at ESC 2026 – ESO